FindTrial
Sign In

Clinical study on human chorionic gonadotropin (HCG) detection kit (latex immunochromatography)

Clinical study on human chorionic gonadotropin (HCG) detection kit (latex immunochromatography)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080738
Enrollment
Unknown
Registered
2024-02-06
Start date
2024-02-06
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Gold Standard:Beckman DXI800 methodology (chemiluminescence method) for detecting the level of HCG in serum
Index test:human chorionic gonadotropin (HCG)

Sponsors

Hebei Maternity Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Women receiving assisted reproductive technology treatment. (2) The relevant information of the sample is complete, including age, clinical diagnostic background information, sample type, sample date, etc.

Exclusion criteria

Exclusion criteria: (1) The sample cannot be traced or the sample information is incomplete. (2) The sample size is insufficient to meet the measurement requirements. (3) Samples with severe lipid, hemolysis, chyluria, hematuria, turbidity, and contamination.

Design outcomes

Primary

MeasureTime frame
human chorionic gonadotropin (HCG) in serum;human chorionic gonadotropin (HCG) in serum;—

Secondary

MeasureTime frame
human chorionic gonadotropin (HCG) in urine;human chorionic gonadotropin (HCG) in urine;—

Countries

China

Contacts

Public ContactLiyi Cai

Reproductive Medical Center of Hebei Maternity Hospital

cai760829@163.com+86 159 6188 1808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026